Making your research project happen: challenges, facilitators and tips for planning by Markham, Chris et al.
[  162  ]
Basic Research For Clinicians
Making Your Research Project Happen – Challenges, 
Facilitators and Tips for Planning
Christian Markham, PhD, Ann Dewey, PhD, Amy Drahota, PhD, Carole Fogg, MSc, Paul R Kalra, MD, Rebecca 
Stores, PhD, Donah Zachariah MBBS, MRCP, Sally Kilburn, PhD, Hampshire, UK
This article describes some of the important processes to consider when planning the implementation of a research project. Key organizations and external links are 
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ABSTRACT
Introduction
So you want to do research? You have selected a topic 
for your research and developed your ideas into focused 
research question(s) with clear objectives. You know 
which data you will collect and how you will collect 
it. It is tempting to rush out and start collecting data. 
WARNING: research is a slow process, patience is 
crucial, and careful planning is the key to success.  
It is easy to be wise after the event! At the end of your 
research study you will know how much time and effort 
it took. Hopefully, you will not be disappointed with 
the final results. Sadly, many researchers are finding it 
difficult to understand why the findings are not what they 
had hoped for, often as they had not achieved the quality 
project they initially had in mind. Achieving excellence 
in research involves patience; a good beginning to 
implementing the project requires a careful, considered 
process - if activities are rushed and uncoordinated, 
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shortfalls will occur. Is your research feasible given the 
time and resources you have available? It is important to 
identify risks in implementation and when these might 
occur, and put into place contingency plans. Be clear from 
the beginning about the legal and ethical responsibilities 
and accountability of the research team. Who are the 
important people to involve from the outset? Do you 
or your team have training needs? How will you fund 
training, buy equipment and the resources required? 
Asking and seeking answers to these questions now may 
seem unnecessary, time-consuming bureaucratic steps, 
but early planning can save time and resources in the 
long run, and lead to a better quality project.
In this article, we have set out to provide a comprehensive, 
although not exhaustive, discussion of research project 
planning in order to illustrate the bigger picture of what 
you need to consider ensuring the successful completion 
of your research study. 
Feasibility of Delivery
It is important to consider how feasible a proposed 
research project is at the outset. Being focused, realistic 
and aiming to achieve what can reasonably be done 
within the time, expertise and resource constraints 
under which you are working are all important factors 
to consider. It is easy to overestimate how much can be 
accomplished and it is crucial to ensure the research plan 
is actually achievable. Considering some of the points 
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below should help with this:
•	 Can the project be completed within the time 
available? You will need to take account of time 
for all aspects of setting up (including gaining 
permissions), piloting, data collection and coding, 
analysis, writing up and dissemination. Allowing 
leeway for unforeseen circumstances is advisable.
•	 Is the study too complex and over ambitious 
given the resources available? It is easy to get 
overenthusiastic and be under the impression that 
your study will answer many more questions than it 
realistically can.
•	 Are the required resources available? Most projects 
require a range of resources, some more obvious 
than others. These will vary enormously depending 
on the nature of the research but may include access 
to literature, equipment, participants, data, expertise, 
funding and so on. You need to bear in mind the 
availability and accessibility of the resources for 
any given project.
•	 What skills are needed by staff working on the 
project and are there training needs associated with 
these? You need to identify these as early as possible 
and make an informed judgment about whether 
the necessary training can be provided within the 
available time and funding.
•	 Are the recruitment procedures going to work? 
Most research involves inviting participants, either 
patients, carers, or healthcare professionals, to 
consent to undergo research-related procedures, 
for example questionnaires or interventions. 
However, the rate of recruitment is often over-
estimated, leading to a lengthened period required 
to complete the study, or the study having to finish 
data collection before the desired sample size is 
reached. This is often referred to as Lasagna’s Law 
(Day, 2007). Disappointment on this account can 
be avoided by careful attention to study design and 
early discussion with stakeholders regarding the 
recruitment process. 
Patient and Public Involvement 
It is now widely acknowledged that patient and public 
involvement (PPI) in research is important to ensure 
the relevance, applicability, and appropriateness of 
research activities (Brett et al., 2012). Many funding 
bodies now include an assessment of how well you are 
incorporating PPI into your research when they decide if 
your study is worth funding. PPI should be a meaningful 
activity, incorporating the knowledge and experience 
of those with interest in your research. PPI can take 
many forms, and the level of engagement varies from 
involving people in an advisory capacity, to more active 
‘co-production’ of the research. PPI should take place 
from the very beginnings of your research when you are 
shaping the research question, deciding on the important 
outcomes, and explaining the research plan in ways that 
are clear, non-patronizing, and free of medical jargon. At 
a later stage, PPI actions can include having members of 
the public sitting on steering committees and informing 
decisions, helping with the recruitment strategy (for 
example by designing the information sheets and letters 
of invitation), co-producing the research with you (for 
example through peer-to-peer interviews),  right through 
to facilitating with the dissemination activities. In the 
UK, the advisory group ‘Involve’ offer many guidelines 
and resources for involving members of the public, and 
these contain useful messages applicable to other settings 
as well (www.invo.org.uk/). One example of a project 
involving members of the public is an interview study 
carried out in Manchester, UK, exploring the factors 
influencing how people undertaking caring activities 
for someone with vascular disease come to be defined 
as a carer (http://www.invo.org.uk/resource-centre/
research-project-database/research-project/?id=743). 
In this project members of the public were involved in 
finding and designing appropriate ways of approaching 
participants, prioritizing topic areas, planning the 
research, managing the research, analyzing the research, 
and applying for funding.
Building an Experienced and Qualified 
Team, and Nurturing Juniors
When carrying out research, it is important to have a good 
team around you with the necessary skill mix, expertise, 
and capacity to contribute to the research design chosen 
to address your question. Consider complementary skill 
sets when formulating your team, for example, you 
may need to bring together varied skills such as clinical 
leads, methodology experts, statistician, laboratory 
scientists, patient public involvement member, project 
manager and ethics and governance expert. Some team 
members may have expertise across these domains, 
and others may require training, for example in ‘Good 
Clinical Practice’. The ‘International Conference 
on Harmonisation of Technical Requirements for 
Registration of Pharmaceuticals for Human Use’ (ICH) 
developed the E6 Guideline for Good Clinical Practice 
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(1996), known as ICH GCP. This is an “international 
ethical and scientific quality standard for designing, 
conducting, recording and reporting trials that involve 
the participation of human subjects. Compliance with 
this standard provides public assurance that the rights, 
safety and well-being of trial subjects are protected, 
consistent with the principles that have their origin 
in the Declaration of Helsinki (http://www.wma.net/
en/30publications/10policies/b3/), and that the clinical 
trial data are credible.” (ICH Guideline For Good 
Clinical Practice E6(R1), 1996). Having a mix of junior 
and senior researchers facilitates learning and capacity 
building. Additionally, identifying areas of the research 
project that could be carried out by juniors and written-
up as part of an educational qualification is a worthwhile 
investment for the institution.
Budgeting a Study
Every research project has associated costs. If you are 
applying for a grant to cover the study, or requesting the 
resources from your institution, it is important to have 
a well-planned budget (Hulley et al., 2006). Costs fall 
into six main areas: staff, equipment, consumables, costs 
for participants, administrative and dissemination costs. 
Your institution may also apply ‘overhead’ costs (i.e. to 
cover the office/laboratory space, energy usage, etc.), 
so it is important to work with the professional services 
within your institution in order to gain approvals for 
your proposed work and budget plan. 
Staff costs are often the largest expense for any research 
project. Most projects require a multidisciplinary team 
and may need small amounts of time to be contributed 
from a large range of people – for example qualitative 
researchers, statisticians, health economists – who will 
need to plan how much time their individual contribution 
will require, and assign a cost to it. There will also be 
staff, who need to be recruited and paid full-time for 
the study duration, for example research assistants, data 
entry clerks and laboratory technicians. PPI members 
also need their costs considered – for example their 
time, travel expenses, reimbursement for child/spouse 
whilst they attend activities. Members of any groups, 
who are supporting the study, for example the Data 
Monitoring Committee or the steering group, will also 
require reimbursement for time and travel. 
Equipment costs will depend on what is already available 
and what you need to purchase for the study – ensure 
that if equipment is currently in use for clinical activities 
and is also intended to be used in the research project 
that the workload and planning for the equipment and 
the operator is feasible availability of equipment does 
not necessary mean that it will be free for use for the 
research project. If you are collecting and analyzing 
large data sets, you may need to consider access to 
networked computer systems to share data. It might be 
necessary to buy a new computer with sufficient memory 
or purchasing additional high volume storage devices. 
The purchase of a laptop for collecting data in the field 
might be useful.  Some further considerations, related to 
the data type:
Quantitative Data:
•	 If you do not currently have the support of a 
statistical advisor, will you need to pay for statistical 
advice, for example a consultant?   
•	 Do you require specialized computer software (such 
as SPSS) for analyzing your quantitative data and 
will you require training to use it?
Qualitative Data: 
•	 Do you need to purchase video or audio equipment 
to record observational or interview data?  
•	 Lengthy audio recorded interviews will require 
transcribing; do you have the time to type up the 
interviews or will it be possible to pay somebody 
else to do this for you?  
•	 For qualitative data storage and analysis you might 
benefit from using qualitative computer software 
(such as NVivo (http://www.qsrinternational.com/), 
or MAXQDA - http://www.maxqda.com/) for which 
you will need to purchase personal or multiple users 
license and relevant training. Such training may be 
costly and will require appropriate funding.    
Consumables need to be estimated based on the number 
of participants you require for the study, and the number 
and type of tests or procedures they will undergo. Any 
additional consumables for the research project over 
and above those used for routine clinical care need to be 
costed. It is common for participants to be reimbursed 
for their travel expenses, and sometimes for their time, 
or provided with a token of thanks for their participation, 
such as a small gift. 
All research generates a considerable amount of 
paperwork and communications – costs for an 
administrative assistant and all necessary office supplies 
are therefore vital to provide an administrative hub for 
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the study. Disseminating the results of the study is also 
an important activity – funds for printing posters, travel 
expenses and subsistence for conferences, publication 
fees and organizing dissemination workshops need to be 
included in the budget. Other miscellaneous costs may 
include fees for approvals from regulatory bodies, fee to 
register clinical trials, purchasing of clinical datasets, and 
advertisements and website information about the study.
Funding 
Given the numerous costs of a study, funding is crucial - 
without it, research cannot take place. The cost of carrying 
out a study will vary according to its size, nature and 
length of time. During the planning stage of a potential 
study, it will be necessary to forecast its potential cost 
and for many studies, this will be greatly supported by 
advice from a finance officer who is aware of local costs 
and formulae for calculating them. Fortunately, there 
are numerous funding options available to researchers. 
These include local, national and international bodies 
who seek to support the generation of new knowledge 
about healthcare, such as government agencies, charities 
and Universities. Typically, these different providers of 
funding will have an area of clinical or social interest 
they wish to support and it is important when considering 
who to apply to for funding whether a proposed study 
falls within one of the funder’s areas of interest. This 
is because, unfortunately, there is not a limitless supply 
of research funding and therefore funding committees 
make judgments about a potential study’s overall likely 
benefit and value for money.  
There is usually an application process to a funding body, 
which is likely to include a requirement for information 
about the justification for a proposed study, how the 
study will be conducted and managed, and how much it 
will cost – i.e. what they are being asked to fund. This 
is a competitive process that requires time and expertise 
in both the clinical field of study and the research itself; 
for these reasons successful applications are often made 
by teams of individuals with a range of knowledge and 
experience. Funding applications need to contain a 
rigorous discussion of the current literature regarding 
the area of interest and show where the proposed study 
fits within this. It also requires significant amount of 
technical information regarding the research methods 
proposed, such as sampling, data collection and analysis 
and how the findings of a study may influence future 
clinical practice. This level of knowledge and detail 
indicates why it is useful to assemble a team of colleagues 
to prepare and conduct a study, and also justifies seeking 
the advice of specialists such as statisticians, economists 
and research methodologists.
Ethics and Governance 
An important principle and process of the research 
journey are ethical considerations and opinions. 
All research, and particularly that including human 
participants, should be underpinned by accepted ethical 
principles. Research ethics are universally accepted 
ideas and approaches to the justification and conduct of a 
study and are principally concerned with the interests of 
society and human participants within any research study. 
Ethically, research is expected to have a potential benefit 
to a society and should aim not to harm any participants 
within it. Although the moral values guiding ethical 
opinion are relative, an excellent source of guidance 
for cardiologists are the World Medical Association’ 
s principles enshrined in the Declaration of Helsinki 
(2008).  In addition to these international guidelines 
are a range of interpretations of research ethics found 
in professional guidance such as the General Medical 
Council in UK and research funding and governance 
agencies such as the UK’s Medical Research Council 
and the American Psychological Association.
All of these various guidelines resonate a fascinating 
history of medical and research ethics since the time 
of Hippocrates over two thousand years ago. However, 
it is interesting that the core ideals have remained 
largely unchanged over this period of time and focus 
on minimizing any harm experienced by research 
participants. Research ethics therefore seeks to protect 
the individual and society and defines harm broadly.  For 
example, harm can include physical pain, psychological 
distress and or a lack of respect for a participant’s 
dignity. Fortunately, there are numerous practices that 
help researchers reduce potential harm. In terms of 
distress and physical pain, it is useful to consider what is 
known as the risk benefit ratio. This test considers that 
research with an elevated risk of causing harm should 
be balanced by a higher likelihood of leading to benefit 
for research participants. Conversely, studies with 
minimal or even potentially no benefit are justifiable on 
the grounds that they also are unlikely to lead to any 
harm. The idea of harm also includes an individual’s 
dignity and respect. Here researchers can firstly consider 
whether the participants they seek to include are in any 
way vulnerable, for example in the case of children and 
mentally incapacitated adults. Vulnerable members of 
society should not be excluded from research, indeed 
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it would be unethical to do so, however, their inclusion 
should be well justified and their involvement supported 
accordingly.  
This latter point leads to a central principle of reducing 
the risk of harm to a person’s dignity and respect, which is 
that of informed consent.  Informed consent to participate 
in a research study is a universal ethical principle and 
in many countries can also be a legal requirement. It 
concerns the idea that human participants should, in some 
way, be aware that they are participating in research, that 
they have the right not to participate, or withdraw once 
they have started, and should be provided with sufficient 
information and time to consider it before independently 
deciding and agreeing to take part. Ultimately this means 
that individuals cannot be compelled to participate in 
research and should be provided with clear information 
about the study and what their participation will involve. 
In the case of vulnerable groups, this has to be considered 
carefully according to the reason for vulnerability 
and therefore the individual’s ability to understand 
the implication of their inclusion and provide a truly 
informed, independent and reasoned opinion. Finally, 
research respects dignity when it protects information 
about participants and it is always important to maintain 
high levels of confidentiality, particularly with patient 
data that has been collated for reasons unrelated to any 
treatment they may be receiving.
Ethical principles, such as those illustrated above, 
should be considered during the planning stage of a 
study and certainly discussed in a research proposal. 
However, in the case of research, before a study may 
commence it will require a favorable opinion from an 
ethics committee. Research ethics committees should 
reflect the diversity of individual’s within a society and 
take on the responsibility of providing an opinion about 
the ethics of a proposed study that would be reflected 
in the wider community. Researchers should identify 
the relevant committee (Hospital, University, Funder) 
that they should consult for an opinion and complete 
an application for an opinion. This usually involves 
detailing the justification for the proposed research and 
the nature of involvement of any human participants, in 
particular who will be approached to participate, how 
they will be approached and what they will be asked 
to do during their participation. Committees consider 
these points against accepted principles of research 
ethics and ultimately form an opinion of the risk benefit 
ratio. The committee will communicate their decision to 
the research team, who are hoping it will be favorable 
and therefore allow them to pursue other areas of 
research governance. There are close links between the 
ethics committee and the ‘sponsor’ of the study – i.e. 
the organization who takes overall responsibility for 
conducting the study (e.g. a pharmaceutical company, 
a University or a healthcare delivery institution). Issues 
arising from the study delivery which may affect 
patients’ rights and safety, for example serious adverse 
events, are reported regularly to the ethics committee by 
the sponsor, and the ethics committee is always available 
to provide advice on study conduct post-approval.
Regulatory Aspects
All research normally takes place within a national 
framework. For example, the UK government 
produced the Research Governance Framework for 
Health and Social Care which outlines the standards 
to which the research structure should operate, where 
responsibilities and accountabilities lie, what the 
systems are for research delivery, and monitoring and 
inspection processes to detect failures (http://www.
dh.gov.uk/en/Publicationsandstatistics/Publications/
PublicationsPolicyAndGuidance/DH_4108962).  Bodies 
such as Ethics Committees, Research and Development 
departments within health delivery institutions and the 
Medicines and Healthcare Regulatory Agency work 
together to form a system of processes and approvals 
to ensure that research carried out is safe for patients, is 
appropriate to take place within the health structure and 
is properly resourced.
There are other international forms of guidance relating 
to health research and clinical trials in particular, notably 
the International Conference of Harmonisation (ICH) 
Good Clinical Practice (GCP) guidelines (http://ichgcp.
net/). Although this document was developed to guide the 
requirements for pharmaceutical products for human use, 
it has been widely adopted as a standard for investigators 
for all types of research. It provides a structure for 
investigators to ensure that the rights and safety of trial 
participants are protected, and contains much detail 
relating to appropriate documentation for studies, so 
that an appropriate audit trail could check whether the 
data and reported results are credible and accurate. This 
guidance was adopted as a legal requirement for clinical 
trials of investigational medicinal products (CTIMPs) 
in Europe in 2005 (http://ec.europa.eu/health/human-
use/clinical-trials/index_en.htm). This means that the 
sponsors of the studies have to put in place monitoring 
procedures to ensure that these principles are being 
adhered to for the course of the study.
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Dissemination 
You should plan your dissemination strategy before 
you even begin your research. Consider where you will 
publish, agree who will be included as authors (or at 
least the principles that will govern this decision), and 
what will be the different modes of dissemination. When 
it comes to writing up your research, it is important to 
consider who you are writing it for. You will want your 
research to have an impact, to inform practice and further 
research in the field. You should be transparent about 
what you did and did not do, and remain true to your 
original research plan (i.e. do not switch your original 
primary outcome for one that shows a more favorable 
result!). It may be tempting to put a positive spin on 
results, which actually showed no significant difference; 
however this can result in bias, making it harder for 
people to determine what actually does not work (or is 
even harmful), and what may be worth disinvesting in. 
A well planned and conducted study will be informative 
regardless of the findings, and you have a duty to those 
who took part in and supported the research to get the 
results out in the public domain to help inform future 
decisions. There are reporting guidelines to help with 
writing up all manner of study design types; you should 
plan to utilize the relevant guide and ensure that you are 
collecting the appropriate information throughout the 
research to accomplish this. The EQUATOR network 
(Enhancing the QUAlity and Transparency Of health 
Research) has compiled these guidelines in an online 
resource centre (http://www.equator-network.org/
resource-centre/library-of-health-research-reporting/). 
Also consider the different routes to dissemination;  as 
well as researchers, you will probably want to consider 
policy makers, practitioners, and members of the 
public. Different audiences may read different types 
of journals or magazines, or prefer different modes of 
delivery. Although the high impact factor journals will 
most likely be a place you want to publish in order to 
progress your own career and reach your peers, you may 
also want to consider the use of newsletters/magazines, 
public seminars, and social media as additional methods 
of getting your message out to those whom the research 
can have most impact. Another important consideration 
is how accessible your chosen journal is; does it operate 
an ‘open access’ policy which will enable the end users 
to access the paper (either immediately on publication or 
after some delay), or will your research be hidden behind 
a pay-wall making it less accessible and less likely to 
reach your target audience. Some journals provide a 
payment option for making your research open access 
(indeed some funders now require you to publish in an 
open access resource); a well-planned study will have 
considered this, and incorporated the publishing costs 
into the funding plan.
In short, careful planning and consideration of all 
stages of the research journey, will help overcome 
potentially stressful situations, and provide you with 
the best opportunity for smooth transition through the 
research project. There will be the inevitable unexpected 
eventualities; however with a good team around you, 
and support systems in place, you may experience the 
rewards of undertaking research in a field that you feel 
passionate about.
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